We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Frozen Cell Line Available for Enterovirus Diagnosis

By HospiMedica staff writers
Posted on 14 Aug 2007
The smallest clinical laboratories can use a new frozen cell line for enterovirus diagnosis.

The ReadyCells are provided as confluent monolayers in shell vials and stored frozen at -70° C for up to six months, allowing laboratories to keep the cells from a single production lot available while minimizing cell waste. More...
Cells are thawed on the ReadyCells heat block as needed and ready to inoculate with clinical specimens in four minutes.

ReadyCells provides flexibility to all virus culture labs. Large users gain benefit when the test volume exceeds expectations, and the frozen inventory helps eliminate weekly shipping costs for smaller volume laboratories. International customers benefit from access to cell systems such as R-Mix and Super E-Mix, which otherwise would not be possible due to extreme shipping stress. In all cases, ReadyCells remains frozen and useful until the user needs them.

ReadyCells is a new product developed by the Diagnostic Hybrids (Athens, OH, USA; www.dhiusa.com) for their of enterovirus detection line. Other products include flocked swabs for specimen collection, universal transport medium for specimen transport, and the D3 IFA enterovirus identification kit.

Diagnostic Hybrids invents, develops, manufactures, and sells diagnostic and analytic products for a wide range of viral respiratory diseases, herpes virus infections, and other specific viral and thyroid diseases. The company also develops and commercializes genetically engineered cell-based detection products for the pharmaceutic and biotechnology industry, with an initial focus on pharmacology assays and products that measure drug clearance and anti-viral interventions with drugs and vaccines.


Related Links:
Diagnostic Hybrids

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.